市場調査レポート

商品コード

1235928

持続的腎代替療法の世界市場：2028年までの予測- 製品、モダリティ、年齢層、エンドユーザー、地域別

Continuous Renal Replacement Therapy Market Forecasts to 2028 - Global Analysis By Product, Modality, Age Group, End User and Geography

出版日: 2023年03月03日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 175+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 650,554円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,990円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 995,426円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,175,700円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の持続的腎代替療法（CRRT）市場は、2022年に13億1000万米ドルを占め、2028年には22億3000万米ドルに達すると予測され、予測期間中に9.3%のCAGRで成長するとされています。

急性腎障害（AKI）の重症患者、特に血行動態が不安定な患者に対する一般的な治療法は、持続的腎代替療法（CRRT）です。これは、血液濾過、血液透析、またはその2つの組み合わせによって血液から溶質を除去するプロセスを含みます。

米国病院協会によると、2021年の国内には、連邦政府病院が208、連邦政府以外の精神科病院が625、地域病院が5,141存在します。また、AKI入院患者の大幅な増加や老年人口の増加により、CRRTシステムの需要が高まっており、市場拡大の原動力となっています。

市場力学

促進要因

急性腎障害と慢性腎臓病の増加

急性腎不全の主な危険因子は、糖尿病、高血圧、高齢化です。糖尿病の有病率は世界的に急速に上昇しています。その結果、急性腎不全の患者数は、糖尿病の有病率とともに増加しています。医療関係者の意識の高まりにより、急性腎障害の発生を抑制し、高齢者における基礎疾患の管理を強化することが期待されます。

阻害要因

高い治療費

新興国の人々は、手頃な価格を重視するため、低価格の商品を好んで購入します。発展途上国ではコストが高いにもかかわらず、国民の多くは購買力が低いため、こうした手段をとることができないです。このため、先進国と発展途上国の両方で、この治療法に対する需要と導入が制限されています。

機会

新しい技術の導入

機器設計における技術の進歩は、重症患者における治療の使用に大きく寄与しています。これらの技術革新は、ICUにおける体外療法の幅を大きく広げています。さらに、ソフトウェアの統合は、最先端の機械のための全く新しいツールとして登場する可能性が高いです。

脅威

厳しいヘルスケア規制

企業は、既存の多くの法律や規制の適用を受けるため、規制環境の変化に対して脆弱であり、コンプライアンス違反は、企業の業務、財務状況およびビジネスに悪影響を及ぼす可能性が高いです。ヘルスケア業界参入企業として、企業の業務や商品が様々な政府規制の対象となることは、市場拡大の妨げとなります。

COVID-19の影響

COVID-19の全体的な影響は、市場にとって依然としてポジティブなものです。パンデミックは、世界規模で腎代替液の需要を大幅に増加させました。過去の米国の人口と比較すると、COVID-19患者のRRTに対する需要は5倍に増加しています。例えば中国やイタリアでは、AKI率が29％と高いことが報告されています（国際腎臓学会2020年版の研究）。COVID-19の感染によって増加傾向にあるAKIの発生率を下げるためには、持続的腎代替療法（CRRT）を早期に実施することが重要です。

予測期間中は持続的静脈血液濾過療法（CVVHDF）セグメントが最大になると予想される

連続静脈性血液濾過（CVVHDF）セグメントは、透析処置の増加により、有利な成長を遂げると推定されます。この治療法は、血液中の溶質と体液を包括的に除去・交換するものです。また、拡散と対流の原理も含まれているため、市場の成長を後押ししています。

予測期間中、成人が最も高いCAGRを示すと予想されます。

成人向けは、様々な規制当局の承認や新製品開発の増加により、予測期間中に最も速いCAGRの成長が見込まれます。また、様々な市場関係者が様々な成長戦略を採用していることも、この分野に有利な機会を生み出しています。

最もシェアの高い地域

アジア太平洋地域は、技術進歩やヘルスケア支出の増加により、予測期間中に最大の市場シェアを占めると予想されます。これは主に、製品の研究開発への投資強化に伴う取り組みの増加に起因しています。さらに、主要メーカーが地理的プレゼンスの拡大に注力していることも、この地域の成長を促進する要因となっています。

CAGRが最も高い地域

欧州は、高齢者人口の増加や急性腎障害の増加により、予測期間中に最も高いCAGRを示すと予測されます。持続的腎代替療法における新技術の採用率の高さと、確立されたヘルスケアインフラの存在が、この地域全体の市場の成長を大きく後押ししています。

主な発展

2021年2月、DaVitaは安全な遠隔医療プラットフォーム「DaVita Care Connect」を在宅透析プログラムに組み込むことで、最初のポジションを達成しました。これは、在宅治療を決定した患者の転帰とケア体験を改善するために設計された同社のサービス群における様々な接続技術の1つです。

2020年12月、メドトロニックplcはカルペディエム心筋腎小児透析緊急装置の発売を発表しました。この手技は、血液透析を必要とする急性腎障害や体液過多の患者に使用することが適応となります。体重2.5～10kgの患者さんに持続的腎代替療法（CRRT）を供給する予定です。

2020年4月、透析製品とサービスの世界的プロバイダーであるフレゼニウス・メディカル・ケアは、パンデミック危機における進行した慢性腎臓患者の臨床ケアの原則を呼びかけるアドバイザリーを発表したことを明らかにしました。アドバイザリーでは、COVID-19危機の際に腎代替療法が必要な患者さんについても、医師と相談の上決定した治療を提供すべきとしています。

私たちのレポートが提供するもの

地域レベルおよび国レベルセグメントの市場シェア評価
新規参入企業への戦略的提言
2020年、2021年、2022年、2025年、2028年の市場データを網羅
市場促進要因（市場動向、制約要因、機会、脅威、課題、投資機会・推奨事項など）
市場推定に基づく主要なビジネスセグメントにおける戦略的な提言
競合情勢とその動向
詳細な戦略、財務、最近の動向を含む企業プロファイル
サプライチェーンの動向は、最新の技術進歩をマッピングしています。

無料カスタマイズの提供

本レポートをご購入いただいたお客様には、以下のいずれかの無料カスタマイズをご提供いたします。

企業プロファイル
- 追加市場企業の包括的なプロファイリング（最大3名まで）
- キー企業のSWOT分析（3名まで）
地域別セグメント
- お客様のご希望により、主要国の市場推計・予測・CAGRを提供（注：フィージビリティチェック別）
競合ベンチマーキング

製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第11章企業プロファイル

Asahi Kasei Corporation
B. Braun Medical Inc.
Baxter International Inc.
Chongqing Shanwaishan Science and Technology Co., Ltd.
Fresenius Medical Care AG & Co. KGaA
Infomed SA
Medica SpA
Medical Components, Inc.
Medites Pharma Spol. S.R.O.
Medtronic PLC
Nikkiso Co., Ltd.
Ningbo Tianyi Medical Appliance Co., Ltd
NIPRO Corporation
NxStage Medical, Inc.
Toray Medical Co., Ltd.

図表

List of Tables

Table 1 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
Table 3 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 4 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
Table 5 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
Table 6 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
Table 7 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 8 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
Table 9 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
Table 10 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
Table 11 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 12 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 13 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 14 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
Table 15 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
Table 16 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
Table 17 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
Table 18 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
Table 19 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 20 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 21 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
Table 22 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
Table 23 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
Table 24 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 25 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
Table 26 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
Table 27 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
Table 28 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 29 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
Table 30 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
Table 31 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
Table 32 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 33 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 34 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 35 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
Table 36 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
Table 37 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
Table 38 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
Table 39 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
Table 40 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 41 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 42 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
Table 43 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
Table 44 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
Table 45 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 46 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
Table 47 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
Table 48 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
Table 49 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 50 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
Table 51 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
Table 52 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
Table 53 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 54 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 55 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 56 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
Table 57 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
Table 58 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
Table 59 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
Table 60 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
Table 61 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 62 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 63 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
Table 64 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
Table 65 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
Table 66 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 67 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
Table 68 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
Table 69 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
Table 70 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 71 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
Table 72 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
Table 73 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
Table 74 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 75 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 76 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 77 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
Table 78 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
Table 79 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
Table 80 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
Table 81 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
Table 82 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 83 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 84 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
Table 85 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
Table 86 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
Table 87 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 88 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
Table 89 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
Table 90 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
Table 91 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 92 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
Table 93 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
Table 94 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
Table 95 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 96 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 97 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 98 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
Table 99 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
Table 100 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
Table 101 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
Table 102 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
Table 103 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 104 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 105 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
Table 106 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
Table 107 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
Table 108 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 109 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
Table 110 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
Table 111 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
Table 112 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 113 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
Table 114 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
Table 115 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
Table 116 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 117 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 118 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 119 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
Table 120 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
Table 121 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
Table 122 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
Table 123 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
Table 124 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 125 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 126 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)

Product Code: SMRC22525

According to Stratistics MRC, the Global Continuous Renal Replacement Therapy (CRRT) Market is accounted for $1.31 billion in 2022 and is expected to reach $2.23 billion by 2028 growing at a CAGR of 9.3% during the forecast period. A common form of treatment for critically ill patients with acute kidney injury (AKI), particularly those with unstable hemodynamics, is continuous renal replacement therapy (CRRT). It includes the process of removing solutes from blood via hemofiltration, hemodialysis, or a combination of the two.

According to the American Hospital Association, there were 208 federal government hospitals, 625 nonfederal psychiatric hospitals, and 5,141 community hospitals in the country in 2021. The demand for CRRT systems is also rising due to the significant rise in AKI hospital admissions and the growing geriatric population, which is fueling market expansion.

Market Dynamics:

Driver:

Increase in acute kidney injury and chronic kidney diseases

The main risk factors for acute kidney injury are diabetes, hypertension, and an ageing population. Diabetes prevalence is rising quickly across the globe. As a result, the number of patients with acute kidney injury is growing along with the prevalence of diabetes. Growing awareness among medical professionals could lessen its occurrence and enhance the management of underlying diseases in the elderly population.

Restraint:

High procedural cost

People in emerging economies value affordability, so they favour lower-cost goods. Despite the high cost in developing nations, a large portion of the population cannot afford these measures because of their low purchasing power. This restricts both the developed and developing world's demand for and adoption of this therapy.

Opportunity:

Implementation of new technologies

Technology advancements in equipment design have greatly benefited the use of therapy in critically ill patients. These innovations have significantly broadened the scope of extracorporeal therapies in the ICU. Additionally, software integration is likely to emerge as a brand-new tool for cutting-edge machinery.

Threat:

Stringent healthcare regulations

Companies are vulnerable to a changing regulatory environment because they are subject to a number of existing laws and regulations, and non-compliance will likely have a negative impact on their operations, financial condition, and business. The fact that businesses' operations and goods are subject to a variety of government regulations as healthcare industry participants is a hindrance to the market's expansion.

COVID-19 Impact:

The overall impact of COVID-19 remains positive on the market. The pandemic has significantly increased the demand for renal replacement fluids on a global scale. When compared to historical US populations, the demand for RRT among COVID-19 patients has increased five times. China and Italy, for example, reported AKI rates as high as 29%, according to a study by the International Society of Nephrology 2020. Early implementation of continuous renal replacement therapy (CRRT) is crucial for reducing the incidence of AKI, which is on the rise as a result of COVID-19 infection.

The Continuous Venovenous Hemodiafiltration (CVVHDF) segment is expected to be the largest during the forecast period

The continuous venovenous hemodiafiltration (CVVHDF) segment is estimated to have a lucrative growth, due to the increase in dialysis procedures. This treatment modality results in comprehensive removal and replacement of solutes and fluids within the blood. It also includes principles of diffusion and convection, hence propelling the growth of the market.

The Adults segment is expected to have the highest CAGR during the forecast period

The adults segment is anticipated to witness the fastest CAGR growth during the forecast period, due to various regulatory approvals for adult and rise in development of novel products. Additionally, adoption of various growth strategies by various market players are creating lucrative opportunities in the segment.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to rising technological advancement, surging healthcare expenditure. This is primarily attributed to increase in number of initiatives along with enhanced investments for the overall R&D of products. Additionally, surge in focus of leading manufacturers on expanding their geographical presence is the factor driving the region growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to rise in geriatric population and increasing incidences of acute kidney injury. High adoption rates of new technologies in continuous renal replacement therapy and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Key players in the market

Some of the key players in Continuous Renal Replacement Therapy (CRRT) market include: Asahi Kasei Corporation, B. Braun Medical Inc., Baxter International Inc., Chongqing Shanwaishan Science and Technology Co., Ltd., Fresenius Medical Care AG & Co. KGaA, Infomed SA, Medica SpA, Medical Components, Inc., Medites Pharma Spol. S.R.O., Medtronic Plc, Nikkiso Co., Ltd., Ningbo Tianyi Medical Appliance Co., Ltd, NIPRO Corporation, NxStage Medical, Inc. and Toray Medical Co., Ltd.

Key Developments:

In February 2021, DaVita accomplished its first position by including a secure telehealth platform, DaVita Care Connect, into its home dialysis program. It is one of the various connective technologies in its suite of services designed to improve outcomes and the care experience for patients deciding to treat at home.

In December 2020, Medtronic plc announced the launch of the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine. This technique is indicated to be used in acute kidney injury or fluid overloaded patients that need hemodialysis. It is planned to supply continuous renal replacement therapy (CRRT) to patients weighing between 2.5 & 10 kg.

In April 2020, Fresenius Medical Care, a worldwide provider of dialysis products and services, has announced the release of an advisory that calls for clinical care principles for patients with advanced chronic kidney during the pandemic crisis. The advisory states that patients who need renal replacement therapy during the COVID-19 crisis should still be offered the treatment decided in consultation with their physicians.

Products Covered:

Dialysates and Replacement Fluids
Disposables
Hemofilters
Bloodline Sets & Tubes
CRRT Systems
Other Products

Modalities Covered:

Slow Continuous Ultra-Filtration (SCUF)
Continuous Venovenous Hemofiltration (CVVH)
Continuous Venovenous Hemodialysis (CVVHD)
Continuous Venovenous Hemodiafiltration (CVVHDF)

Age Groups Covered:

Adults
Pediatrics /Neonates

End Users Covered:

Hospitals
Ambulatory Centers
Specially Clinics
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Continuous Renal Replacement Therapy (CRRT) Market, By Product

5.1 Introduction
5.2 Dialysates and Replacement Fluids
5.3 Disposables
5.4 Hemofilters
5.5 Bloodline Sets & Tubes
5.6 CRRT Systems
5.7 Other Products

6 Global Continuous Renal Replacement Therapy (CRRT) Market, By Modality

6.1 Introduction
6.2 Slow Continuous Ultra-Filtration (SCUF)
6.3 Continuous Venovenous Hemofiltration (CVVH)
6.4 Continuous Venovenous Hemodialysis (CVVHD)
6.5 Continuous Venovenous Hemodiafiltration (CVVHDF)

7 Global Continuous Renal Replacement Therapy (CRRT) Market, By Age Group

7.1 Introduction
7.2 Adults
7.3 Pediatrics /Neonates

8 Global Continuous Renal Replacement Therapy (CRRT) Market, By End User

8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Centers
8.4 Specially Clinics
8.5 Other End Users

9 Global Continuous Renal Replacement Therapy (CRRT) Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Asahi Kasei Corporation
11.2 B. Braun Medical Inc.
11.3 Baxter International Inc.
11.4 Chongqing Shanwaishan Science and Technology Co., Ltd.
11.5 Fresenius Medical Care AG & Co. KGaA
11.6 Infomed SA
11.7 Medica SpA
11.8 Medical Components, Inc.
11.9 Medites Pharma Spol. S.R.O.
11.10 Medtronic PLC
11.11 Nikkiso Co., Ltd.
11.12 Ningbo Tianyi Medical Appliance Co., Ltd
11.13 NIPRO Corporation
11.14 NxStage Medical, Inc.
11.15 Toray Medical Co., Ltd.